ArticleBMC medical informatics and decision making2026
TumorTwin: a Python framework for patient-specific digital twins in oncology.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Digital Twins in Neuro-Oncology: A Systematic Review of Current Implementations, Technical Strategies, and Clinical Applications.Radiology. Imaging cancer · 2026Pooled it
- Dynamic image-informed selection of biomechanical tumor growth models.Biomechanics and modeling in mechanobiology · 2026Article
- Translational barriers to digital twins in radiation oncology.Physics and imaging in radiation oncology · 2026Article
- Digital Twins in Personalized Medicine: Bridging Innovation and Clinical Reality.Journal of personalized medicine · 2025Review
- Beyond RECIST: mathematical modeling and Bayesian inference reveal the importance of immune parameters in metastatic breast cancer.bioRxiv : the preprint server for biology · 2025Article
- Digital twin framework for postural tachycardia syndrome and autonomic disorders.Frontiers in neurology · 2025Article
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdvances in the theory and methods of computational oncology have enabled accurate characterization and prediction of tumor growth and treatment response on a patient-specific basis. This capability can be integrated into a digital twin framework in which bi-directional data-flow between the physical tumor and the digital tumor facilitate dynamic model re-calibration, uncertainty quantification, and clinical decision-support via recommendation of optimal therapeutic interventions. However, many digital twin frameworks rely on bespoke implementations tailored to each disease site, modeling choice, and algorithmic implementation.
resultsWe present TumorTwin, a modular and differentiable software framework for initializing, updating, and leveraging patient-specific cancer tumor digital twins. TumorTwin is publicly available as a Python package, with associated documentation, datasets, and tutorials. Novel contributions include the development of a patient-data structure adaptable to different disease sites, a modular architecture to enable the composition of different data, model, solver, and optimization objects, and CPU or GPU parallelized implementations of forward model solves and gradient computations. We demonstrate the functionality of TumorTwin via an in silico dataset of high-grade glioma growth and response to radiation therapy.
conclusionThe TumorTwin framework enables rapid prototyping and testing of image-guided oncology digital twins. This allows researchers to systematically investigate different models, algorithms, disease sites, or treatment decisions while leveraging robust numerical and computational infrastructure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.